Your browser doesn't support javascript.
loading
Association between serotonin-norepinephrine reuptake inhibitors and acute angle closure: What is known?
Wicinski, Michal; Kaluzny, Bartlomiej J; Liberski, Slawomir; Marczak, Daria; Seredyka-Burduk, Malgorzata; Pawlak-Osinska, Katarzyna.
Afiliación
  • Wicinski M; Department of Pharmacology and Therapeutics, Faculty of Medicine, Collegium Medicum in Bydgoszcz, Nicolaus Copernicus University, Bydgoszcz, Poland.
  • Kaluzny BJ; Division of Ophthalmology and Optometry, Department of Ophthalmology, Faculty of Medicine, Collegium Medicum in Bydgoszcz, Nicolaus Copernicus University, Bydgoszcz, Poland.
  • Liberski S; Department of Pharmacology and Therapeutics, Faculty of Medicine, Collegium Medicum in Bydgoszcz, Nicolaus Copernicus University, Bydgoszcz, Poland. Electronic address: liberski.slawomir@gmail.com.
  • Marczak D; Department of Pharmacology and Therapeutics, Faculty of Medicine, Collegium Medicum in Bydgoszcz, Nicolaus Copernicus University, Bydgoszcz, Poland.
  • Seredyka-Burduk M; Division of Ophthalmology and Optometry, Department of Ophthalmology, Faculty of Medicine, Collegium Medicum in Bydgoszcz, Nicolaus Copernicus University, Bydgoszcz, Poland.
  • Pawlak-Osinska K; Department of Pathophysiology of Hearing and Balance System, Faculty of Medicine, Collegium Medicum in Bydgoszcz, Nicolaus Copernicus University, Bydgoszcz, Poland.
Surv Ophthalmol ; 64(2): 185-194, 2019.
Article en En | MEDLINE | ID: mdl-30278181
Serotonin-norepinephrine reuptake inhibitors are widely used antidepressants with a relatively safe profile. One of the complications associated with this group of drugs is acute angle closure. The mechanisms linking serotonin-norepinephrine reuptake inhibitors and acute angle closure are complex and may be interlinked with the effects of the drug on the inhibition of serotonin and noradrenaline reuptake, as well as pseudo-anticholinergic effects, dopaminergic effects, and idiosyncratic reactions with the drug molecule in the eye. Individual characteristics, such as polymorphisms of the gene encoding the 2D6 subunit of cytochrome P450, may affect the metabolism of the serotonin-norepinephrine reuptake inhibitor, whereas the combination with other drugs may lead to an increased risk of iridocorneal angle closure and may further exacerbate other mechanisms. Improved knowledge of the mechanisms linking serotonin-norepinephrine reuptake inhibitors and acute angle closure and of the risk factors predisposing to patients to acute angle closure will reduce the number of patients affected by this dangerous complication.
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Glaucoma de Ángulo Cerrado / Inhibidores de Captación de Serotonina y Norepinefrina Tipo de estudio: Etiology_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Surv Ophthalmol Año: 2019 Tipo del documento: Article País de afiliación: Polonia Pais de publicación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Glaucoma de Ángulo Cerrado / Inhibidores de Captación de Serotonina y Norepinefrina Tipo de estudio: Etiology_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Surv Ophthalmol Año: 2019 Tipo del documento: Article País de afiliación: Polonia Pais de publicación: Estados Unidos